Cargando…
The current role of surgery and SBRT in early stage of small cell lung cancer
BACKGROUND: Early stage small cell lung cancer (T1-2N0M0SCLC) represents 7% of all SCLC. The standard treatment in patients with intrathoracic SCLC disease is the use of concurrent chemoradiotherapy (CRT). Nowadays, the recommended management of this highly selected group is surgical resection due t...
Autores principales: | Farré, Núria, Belda-Sanchis, José, Guarino, Mauro, Tilea, Laura, Cordero, Jady Vivian Rojas, Martínez-Téllez, Elisabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Whioce Publishing Pte. Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177012/ https://www.ncbi.nlm.nih.gov/pubmed/34104807 |
Ejemplares similares
-
Robust Optimization of SBRT Planning for Patients With Early Stage Non-Small Cell Lung Cancer
por: Shang, Haijiao, et al.
Publicado: (2020) -
A pilot study of stereotactic body radiation therapy (SBRT) after surgery for stage III non-small cell lung cancer
por: Singh, Anurag K., et al.
Publicado: (2018) -
Stereotactic Body Radiotherapy (SBRT) in Very Limited-Stage Small Cell Lung Cancer (VLS-SCLC)
por: Mercier, Stéphanie L., et al.
Publicado: (2022) -
Dosimetric Feasibility of Dose Escalation Using SBRT Boost for Stage III Non-Small Cell Lung Cancer
por: Hepel, Jaroslaw T., et al.
Publicado: (2012) -
Dose-Escalated Robotic SBRT for Stage I–II Prostate Cancer
por: Meier, Robert
Publicado: (2015)